FDA issued a Warning Letter to Celltex Therapeutics Corporation on 9/24/2012 as a result of this inspection.
FDA investigators audited the Celltex Therapeutics - Sugar Land, TX, United States facility and issued inspectional observations (via FDA 483) on 27 Apr 2012.
Add To Cart
- Category: Biologics
- Inspection end: 27 Apr 2012
- Location: Sugar Land, United States
- FEI: 3009499974